Wellesley Pharmaceuticals Company
Wellesley Pharmaceuticals ensures that the ability of Nocturol to reduce and sometimes eliminate nocturia symptoms can be disseminated.
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
Newtown, Pennsylvania, United States
Founded Date:
2011
Employees Number:
1-10
Funding Status:
Late Stage Venture
Estimated Revenue:
$1M to $10M
Register and Claim Ownership